| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.00033 | 1 |